The global market for biobanking is expected to grow, based on a report by market analysts, ResearchAndMarkets.com. Sources for biobanking continue to diversify and grow.
As medical and dental care continues to become more precise and specialized, the demand for biospecimens and genomics-based information has increased. As a result, biobanks have increased in number since the year 2000.
Another factor behind the growth of biobanks is that government programs and funding have backed research. At the same time, private funding by companies seeking to inform diagnostics and therapeutic research and development has also spurred growth.
An estimated 1,000 biobanks exist worldwide, and they house an estimated 1 billion bio samples. Within these facilities, specialized information like proteomics, metagenomics, and genomics can be gathered for treatment use in disease biology and in initiating personalized medicine. Such information can also be used to inform public health.
Biobanks, including what are referred to as bio libraries and bio repositories, can house reams of potential information for researchers seeking to understand genetic data, to determine biomarkers for particular diseases, and to inform diagnostic development or translational research.
Products 13 October 2026
New Resources Help Dental Exhibitors Evaluate Their Investment and Explore the Personify ShowFlow™ Trade Show Success System
News 13 October 2026
New patient apps extend The Aspen Group’s mission to remove barriers to care, giving patients greater visibility, convenience, and control from booking through treatment
Editorials 13 October 2026
The forerunner of what’s now Texas A&M College of Dentistry opened 120 years ago in Dallas with the mission of educating dentists to provide quality care to patients in North Texas
Oral pathology 13 October 2026
This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...